The FDA has released a draft guidance recommending the reclassification of full-field digital mammography systems from class III to class II. The agency is calling for public comment on the proposal through Aug. 28.
Published in Brief:
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||